Humacyte HUMA
NASDAQ HUMA
$0.66 -0.02 (-3.11%)
As of: Aug 21, 2026 · 11:11 AM EDT

Humacyte (HUMA) EBT Margin (QoQ) (2025 - 2026)

Humacyte (HUMA) EBT Margin (QoQ) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.01 Bn 132.16 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.79 Bn 78.79 Bn 3.93 Bn
3 Argenx Se 65.29 Bn 60.11 Bn 1.37 Bn
4 Moderna 60.18 Bn 55.04 Bn 52.00 Mn
5 BeOne Medicines 42.17 Bn 37.07 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.55 Bn 28.24 Bn 992.69 Mn
7 BioNTech SE 28.45 Bn 10.06 Bn 668.28 Mn
8 Insmed 27.45 Bn 26.29 Bn 358.27 Mn
9 Royalty Pharma 27.19 Bn 26.36 Bn -
10 Humacyte 154.61 Mn 154.61 Mn -825,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -88,779.00
Mar 31, 2026 39,048.00
Dec 31, 2025 480,226.00
Sep 30, 2025 -97,806.00
Jun 30, 2025 -550,553.00